Does SETMELANOTIDE Cause Injection site erythema? 17 Reports in FDA Database
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Injection site erythema have been filed in association with SETMELANOTIDE (Imcivree). This represents 9.3% of all adverse event reports for SETMELANOTIDE.
17
Reports of Injection site erythema with SETMELANOTIDE
9.3%
of all SETMELANOTIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site erythema From SETMELANOTIDE?
Of the 17 reports, 5 (29.4%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for SETMELANOTIDE.
What Other Side Effects Does SETMELANOTIDE Cause?
Nausea (53)
Off label use (48)
Skin hyperpigmentation (43)
Headache (27)
Skin discolouration (26)
Diarrhoea (24)
Vomiting (24)
Fatigue (23)
Decreased appetite (19)
Injection site pruritus (19)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which SETMELANOTIDE Alternatives Have Lower Injection site erythema Risk?
SETMELANOTIDE vs SEVELAMER
SETMELANOTIDE vs SEVOFLURANE
SETMELANOTIDE vs SIBUTRAMINE
SETMELANOTIDE vs SILDENAFIL
SETMELANOTIDE vs SILODOSIN